Todd Golub

Scientific Advisor
Todd Golub

Dr. Todd Golub is a world-renowned physician-scientist, founding member and director of the Broad Institute of MIT and Harvard and faculty member of the Dana-Farber Cancer Institute and Harvard Medical School. In 2014, Golub was elected to the US National Academy of Medicine.

Dr Golub pioneered the application of genomics to cancer biology and therapeutic discovery and was one of the first researchers to use genomic approaches to molecularly characterize human tumors, laying the foundation for the use of genomics to classify, diagnose, and treat cancer. Golub’s innovative use of gene-expression analysis to classify tumors catalyzed the creation of new genomic tools and approaches that have had a lasting impact on cancer research and drug discovery.

He is the recipient of multiple eminent awards, including the Erasmus Hematology Award, the Richard and Hinda Rosenthal Memorial Award, the Outstanding Achievement Award from the American Association for Cancer Research, the Paul Marks Prize for Cancer Research, the E. Mead Johnson Award from the Society for Pediatric Research, and the Judson Daland Prize for Outstanding Achievement in Clinical Investigation from the American Philosophical Society.

Golub has served on the scientific advisory boards of many organizations, including serving as chair of the advisory boards of St. Jude Children’s Research Hospital, the Ontario Institute for Cancer Research, the Sanford Burnham Prebys Medical Discovery Institute, and of the Board of Scientific Advisors of the National Cancer Institute.

Beyond his scientific work, Golub is a passionate supporter of the arts and currently serves on the Board of Trustees of the Boston Symphony Orchestra.

Current Affiliations:
Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute
Harvard Medical School

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science